Details for New Drug Application (NDA): 016785
✉ Email this page to a colleague
The generic ingredient in MATULANE is procarbazine hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the procarbazine hydrochloride profile page.
Summary for 016785
Tradename: | MATULANE |
Applicant: | Leadiant Biosci Inc |
Ingredient: | procarbazine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 016785
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 016785
Suppliers and Packaging for NDA: 016785
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MATULANE | procarbazine hydrochloride | CAPSULE;ORAL | 016785 | NDA | Leadiant Biosciences, Inc. | 54482-054 | 54482-054-01 | 100 CAPSULE in 1 BOTTLE (54482-054-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Expired US Patents for NDA 016785
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | MATULANE | procarbazine hydrochloride | CAPSULE;ORAL | 016785-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription